Page last updated: 2024-08-23

paclitaxel and Ear Neoplasms

paclitaxel has been researched along with Ear Neoplasms in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bhasker, S; Biswas, A; Gandhi, AK; Mohanti, BK; Raza, MW; Roy, S; Saxena, T; Sharma, A; Thakar, A	1
Duffy, K; Friedman, CD; Horwitz, EM; Keenan, E; Langer, CJ; Litwin, S; Nicolaou, N; Ridge, JA; Rosvold, E; Schol, J	1

Trials

1 trial(s) available for paclitaxel and Ear Neoplasms

Article	Year
Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy. Cancer investigation, 2006, Volume: 24, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Ear Neoplasms; Female; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Recombinant Proteins; Salivary Gland Neoplasms; Survival Analysis	2006

Article

Year

Phase I trial of concurrent hyperfractionated split course radiotherapy (HFx RT), cisplatin (cDDP), and paclitaxel in patients with recurrent, previously irradiated, or treatment-naïve locally advanced upper aerodigestive malignancy.

Cancer investigation, 2006, Volume: 24, Issue:2

Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Cisplatin; Combined Modality Therapy; Dose Fractionation, Radiation; Drug Administration Schedule; Ear Neoplasms; Female; Granulocyte Colony-Stimulating Factor; Head and Neck Neoplasms; Humans; Lung Neoplasms; Male; Maximum Tolerated Dose; Middle Aged; Paclitaxel; Radiation-Sensitizing Agents; Recombinant Proteins; Salivary Gland Neoplasms; Survival Analysis

2006

Other Studies

1 other study(ies) available for paclitaxel and Ear Neoplasms

Article	Year
Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience. Auris, nasus, larynx, 2016, Volume: 43, Issue:1 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Ear Canal; Ear Neoplasms; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Otologic Surgical Procedures; Paclitaxel; Prognosis; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tertiary Care Centers; Treatment Outcome; Young Adult	2016

Article

Year

Treatment of squamous cell carcinoma of external auditory canal: A tertiary cancer centre experience.

Auris, nasus, larynx, 2016, Volume: 43, Issue:1

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cancer Care Facilities; Carboplatin; Carcinoma, Squamous Cell; Chemoradiotherapy, Adjuvant; Child; Cisplatin; Disease-Free Survival; Ear Canal; Ear Neoplasms; Female; Head and Neck Neoplasms; Humans; Kaplan-Meier Estimate; Lymph Nodes; Male; Middle Aged; Neck Dissection; Neoadjuvant Therapy; Neoplasm Staging; Otologic Surgical Procedures; Paclitaxel; Prognosis; Proportional Hazards Models; Radiotherapy, Adjuvant; Retrospective Studies; Squamous Cell Carcinoma of Head and Neck; Tertiary Care Centers; Treatment Outcome; Young Adult

2016